Cherine Heesun Kim, MD
Otolaryngology · Loma Linda
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Faculty Physicians and Surgeons of Llusm · Beaver Medical Group P C
Hospitals listed: Loma Linda University Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kim’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A146773 · Current
Licensed to practise in California · since 2017 · expires 2026-10-31 · Loma Linda University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Loma Linda University Medical CenterLoma Linda, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Loma Linda University Health, which runs 4 hospitalsPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.71 (0.47 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.146, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.468, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.383, Oct 2024 – Sep 2025
See every measure and the patient survey for Loma Linda University Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.47 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.146 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.468 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.383 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.66 (0 to 1.53) · 2,053 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 173.35 (135.58 to 211.11) · 169 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 54 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 272 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,758 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,732 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.15 to 0.52) · 8,479 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.88 (1.14 to 4.63) · 2,571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.04 (0 to 2.41) · 933 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.66 to 4.04) · 2,380 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.16 (0.2 to 10.13) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.42 (0.42 to 6.42) · 988 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.91 to 3.67) · 677 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.37 (0 to 0.85) · 7,115 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 37 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.685 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.751 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.702 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.4 · 380 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 660 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.1 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 29.6 · 365 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.5 · 282 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.6 · 513 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (4 to 7.3) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (10.2 to 15.5) · 422 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 89 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.5 · 190 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 18.1) · 720 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 778 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,684 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$29,069
Medicare paid this office $29,069 for 55 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 15 | $1,157 | $72 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 29 | More than 80% of doctors who do this |
Who their Medicare patients are
55 Original Medicare patients in 2024. Average age 74 · Women 55% · Also on Medicaid 29% · Health risk score 1.70. Sicker patients than 9 in 10 peers; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Diabetes 36% · Chronic kidney disease 36% · Heart failure 27% · Atrial fibrillation 24% · COPD 22% · Cancer 20%.
The office billed $139,816, Medicare allowed $37,278 and paid $29,069; for 144 services of 33 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 55 | 144 | 74 | 1.70 | $139,816 | $29,069 |
| 2023 | 36 | 80 | 72 | 2.26 | $74,955 | $15,519 |
| 2022 | 28 | 63 | 69 | 1.51 | $65,257 | $12,484 |
| 2021 | 19 | 21 | 75 | 1.06 | $14,670 | $3,231 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 12 | $1,366 | $98 |
2022: 2 services
| Diagnostic exam of nasal passages using an endoscope | 13 | $2,114 | $163 |
| Return visit (30+ min) | 17 | $2,027 | $107 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 43 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Screening for depression is documented as negative, a follow-up plan is not required | 43 | $0 |
| 2024 | 43 | 1 | 15 | $0 |
| 2022 | 13 | 1 | 13 | $1,650 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 13 | $1,650 |
Drugs they prescribed that Part D paid
$1,854
Pharmacies billed $1,854 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
87 generic and fewer than 11 brand-name prescriptions · $1,854 in drug cost · 60 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 30 | $167 | $5 |
Year by year
| 2024 | 91 | 58 | None | None | $1,854 |
| 2023 | 91 | 57 | None | None | $678 |
| 2022 | 22 | 16 | None | None | $172 |
| 2021 | 15 | 12 | None | 0% | $238 |
| 2020 | 20 | 13 | None | None | $1,325 |
| 2019 | 17 | 13 | None | None | $372 |
| 2018 | 29 | 16 | None | None | $545 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cephalexin | 25 | $139 | $6 |
| Clindamycin | 13 | $58 | $4 |
2022: 1 drug
| Cephalexin | 12 | $93 | $8 |
Money from drug and device companies
$144 in 2023
| 2023 | 1 | 1 | None | $144 |
| 2021 | 2 | 2 | None | $107 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Integra LifeSciences | Integra | $144 | 1 payment
|
See the published payment
| Integra LifeSciences | Meals · 2023-11-15 | Integra | $144 |
See earlier years (2021)
2021: $107
| KLS-Martin L.P. | None | $86 | 1 payment
|
| Galderma Laboratories L.P. | None | $21 | 1 payment
|
Professional record
- NPI
- 1578943189
- Licence
- CA A146773California A146773: Current · expires 2026-10-31
- Trained
- Loma Linda University School of Medicine, 2015
- Group
- Faculty Physicians and Surgeons of Llusm · Beaver Medical Group P C
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2015-06-09
- NPI last updated
- 2020-07-08
- NPI record certified
- 2020-07-08
This is when the NPI record was last certified, not a medical board exam.